PREMIER Biosoft International Releases Version 2 of TMA Foresight, a Statistical Tool for Tissue Microarray Data Analysis.
Palo Alto, California -- May 16, 2007,
PREMIER Biosoft International today announced the release
of version 2 of its new product, TMA Foresight. TMA
Foresight is a statistical tool for tissue microarray
data analysis designed especially for pathologists,
clinicians and researchers.
TMA Foresight enables easy data pre-processing. It helps map the character data to numeric values with a click of a button. Moreover, the measurement level of each variable can be conveniently defined for use in different statistical analysis.
Says Kay Brown, V.P. Business Development and Marketing, "The tissue microarray market, is predicted to grow at 42% per year. We have designed TMA Foresight seeing the need for an easy-to-use specialized data analysis software tool. Version 2 is equipped with a host of advanced statistical tools, designed for pathologists, clinicians and researchers."
About PREMIER Biosoft International
For details, please visit: http://www.premierbiosoft.com/tissue-microarray/index.html